Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Need for early transfusion after CAR T indicates high inflammation and severe acute toxicity, whereas the need for late transfusion is associated with poor remission, higher non-relapse mortality, and shorter survival.”
Title: Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis
Authors: Fan Xia, Bin Lv, Xinyi Li, Mingxi Tian, Xuejiao Gu, Dian Zhou, Qian Sun, Jieyun Xia, Yuekun Qi, Huanxin Zhang, Kunming Qi, Yang Liu, Ying Wang, Wei Chen, Jiang Cao, Zhiling Yan, Ming Shi, Depeng Li, Feng Zhu
You can read the Full Article on BMC Medicine.
You can find other articles featuring Robert Orlowski on OncoDaily.
